全文获取类型
收费全文 | 915篇 |
免费 | 84篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 22篇 |
妇产科学 | 36篇 |
基础医学 | 115篇 |
口腔科学 | 31篇 |
临床医学 | 83篇 |
内科学 | 241篇 |
皮肤病学 | 22篇 |
神经病学 | 31篇 |
特种医学 | 66篇 |
外科学 | 106篇 |
综合类 | 44篇 |
预防医学 | 47篇 |
眼科学 | 1篇 |
药学 | 59篇 |
1篇 | |
肿瘤学 | 91篇 |
出版年
2021年 | 4篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 6篇 |
2015年 | 22篇 |
2014年 | 19篇 |
2013年 | 33篇 |
2012年 | 30篇 |
2011年 | 35篇 |
2010年 | 31篇 |
2009年 | 21篇 |
2008年 | 25篇 |
2007年 | 41篇 |
2006年 | 37篇 |
2005年 | 39篇 |
2004年 | 45篇 |
2003年 | 55篇 |
2002年 | 46篇 |
2001年 | 43篇 |
2000年 | 40篇 |
1999年 | 31篇 |
1998年 | 32篇 |
1997年 | 26篇 |
1996年 | 36篇 |
1995年 | 27篇 |
1994年 | 29篇 |
1993年 | 20篇 |
1992年 | 16篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 14篇 |
1988年 | 21篇 |
1987年 | 12篇 |
1986年 | 18篇 |
1985年 | 20篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 9篇 |
1980年 | 3篇 |
1979年 | 5篇 |
1978年 | 2篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1968年 | 3篇 |
1966年 | 3篇 |
1936年 | 2篇 |
排序方式: 共有1000条查询结果,搜索用时 312 毫秒
1.
2.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
3.
4.
M T Schechter P W Neumann M S Weaver J S Montaner S A Cassol T N Le K J Craib M V O'Shaughnessy 《AIDS (London, England)》1991,5(4):373-379
During 1989, 316 members of a cohort of homosexual men were tested for HIV-specific DNA by the polymerase chain reaction (PCR) using a pair of gag-region primers. Of 125 HIV-seronegative subjects, 123 (98.4%) were PCR-negative while 158 (82.7%) of 191 HIV-seropositive subjects were PCR-positive. Fewer of the 33 subjects who were seropositive and PCR-negative were at Centers for Disease Control (CDC) stage IV than the seropositive, PCR-positive subjects (6 versus 25%; P = 0.030). The seropositive, PCR-negative group had higher mean CD4 counts (640 versus 490 x 10(6) cells/l; P = 0.006), higher CD4: CD8 ratios (0.92 versus 0.64; P = 0.004), lower immunoglobulin (Ig) G levels (1290 versus 1645 mg/dl; P = 0.002), lower IgA levels (168 versus 251 mg/dl; P less than 0.001), and lower C1q binding activity (8 versus 14%; P = 0.010) than the seropositive, PCR-positive subjects. The median rate of CD4 cell decline in the 3 years preceding the PCR sample was less marked in the seropositive, PCR-negative group than the seropositive, PCR-positive group (-58 versus -77 x 10(6) cells/l per year; P = 0.028). To control for duration of infection, we restricted the analysis to the subgroups of 11 seropositive, PCR-negative subjects and 34 seropositive, PCR-positive subjects who had seroconverted earlier in the cohort study. Both subgroups had similar durations of infection, yet the same pattern of differences persisted.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
5.
6.
7.
S. Pearce S.B. Sufi P.J. O'Shaughnessy A. Donaldson S.L. Jeffcoate 《Contraception》1986,34(6):639-646
Gossypol has been shown to inhibit steroidogenesis in leydig cells. This study examined the mechanism of this action by investigating the effect of gossypol on leydig cell hCG receptor binding, adenylate cyclase activity and cyclic AMP production in leydig cells. Gossypol had no effect on hCG binding to cell membranes but inhibited LH-stimulated cyclic AMP production in whole purified leydig cells. It also reduced the stimulation caused by LH, Gpp(NH)p, forskolin and fluoride in membranes from leydig cells and also from liver. It is therefore possible that gossypol affects cyclic AMP production at the level of ATP conversion to cyclic AMP, although effects on the G-protein and catalytic subunit cannot be ruled out. 相似文献
8.
9.
Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate 总被引:5,自引:2,他引:3
We observed that pretreatment of male F344 rats with benzyl selenocyanate,
a versatile organoselenium chemopreventive agent in several animal model
systems, decreases the levels of DNA and RNA modifications produced in the
liver by the hepatocarcinogen 2- nitropropane. To clarify the mechanisms
involved, we pretreated male F344 rats with either benzyl selenocyanate,
its sulfur analog benzyl thiocyanate, phenobarbital or cobalt
protoporphyrin IX; the latter is a depletor of P450. We then determined (1)
the ability of liver microsomes to denitrify 2-nitropropane, (2) effects on
2-nitropropane- induced liver DNA and RNA modifications and (3) amount of
nitrate excreted in rat urine following administration of the carcinogen.
Pretreatment with benzyl selenocyanate or phenobarbital increased the
denitrification activity of liver microsomes by 217 and 765%, respectively,
increased liver P4502B1 by 31- and 435-fold, respectively, decreased the
levels of 2-nitropropane-induced modifications in liver DNA (29-70% and
17-30%, respectively) and RNA (67-85% and 30-50%, respectively), and
increased the 24-h urinary excretion of nitrate by 157 and 209%,
respectively. Pretreatment with benzyl thiocyanate had no significant
effect on any of these parameters. Pretreatment with cobalt protoporphyrin
IX decreased liver P4502B 1 by 87%, decreased the denitrification activity
of liver microsomes by 76%, decreased the 24 h urinary excretion of nitrate
by 88.5%, but increased the extent of 2-nitropropane-induced liver nucleic
acid modifications by 17-67%. These results indicate that the metabolic
sequence from 2-nitropropane to the reactive species causing DNA and RNA
modifications does not involve the removal of the nitro group. Moreover,
they suggest that benzyl selenocyanate inhibits 2-NP-induced liver nucleic
acid modifications in part by increasing its detoxication through induction
of denitrification, although it is evident that other mechanisms must also
be involved.
相似文献
10.